⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for selumetinib sulfate

Every month we try and update this database with for selumetinib sulfate cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade GliomaNCT04166409
Low Grade Astro...
Low Grade Gliom...
Metastatic Low ...
Metastatic Low ...
Biospecimen Col...
Carboplatin
Magnetic Resona...
Quality-of-Life...
Questionnaire A...
Selumetinib Sul...
Vincristine Sul...
2 Years - 21 YearsNational Cancer Institute (NCI)
Selumetinib in Treating Patients With Neurofibromatosis Type 1 and Cutaneous NeurofibromaNCT02839720
Cutaneous Neuro...
Neurofibromatos...
Optic Nerve Gli...
Laboratory Biom...
Selumetinib Sul...
18 Years - National Cancer Institute (NCI)
Selumetinib Sulfate in Treating Woman With Recurrent Low-Grade Ovarian Cancer or Peritoneum CancerNCT00551070
Borderline Ovar...
Low Grade Ovari...
Micropapillary ...
Primary Periton...
Primary Periton...
Recurrent Borde...
Laboratory Biom...
Pharmacological...
Selumetinib
Selumetinib Sul...
19 Years - National Cancer Institute (NCI)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening TrialNCT05564377
Advanced Malign...
Anatomic Stage ...
Anatomic Stage ...
Locally Advance...
Malignant Femal...
Metastatic HER2...
Metastatic Mali...
Recurrent Endom...
Recurrent Fallo...
Recurrent Malig...
Recurrent Malig...
Recurrent Ovari...
Recurrent Prima...
Unresectable HE...
Unresectable Ma...
Alpelisib
Binimetinib
Biopsy
Biospecimen Col...
Bone Marrow Asp...
Bone Scan
Computed Tomogr...
Echocardiograph...
Fluorouracil
Fulvestrant
Ipatasertib
Leucovorin
Magnetic Resona...
Multigated Acqu...
Mutation Carrie...
Neratinib Malea...
Nilotinib Hydro...
Olaparib
Oxaliplatin
Paclitaxel
Palbociclib
Panitumumab
Positron Emissi...
Selumetinib Sul...
Sotorasib
- National Cancer Institute (NCI)
A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade GliomaNCT03871257
Low Grade Gliom...
Neurofibromatos...
Visual Pathway ...
Carboplatin
Magnetic Resona...
Quality-of-Life...
Questionnaire A...
Selumetinib Sul...
Vincristine Sul...
2 Years - 21 YearsNational Cancer Institute (NCI)
Testing the Use of the Combination of Selumetinib and Olaparib or Selumetinib Alone Targeted Treatment for RAS Pathway Mutant Recurrent or Persistent Ovarian and Endometrial Cancers, A ComboMATCH Treatment TrialNCT05554328
Recurrent Endom...
Recurrent Fallo...
Recurrent Ovari...
Recurrent Prima...
Biopsy
Biospecimen Col...
Bone Marrow Asp...
Computed Tomogr...
Echocardiograph...
Multigated Acqu...
Olaparib
Selumetinib Sul...
18 Years - National Cancer Institute (NCI)
Testing the Use of the Combination of Selumetinib and Olaparib or Selumetinib Alone Targeted Treatment for RAS Pathway Mutant Recurrent or Persistent Ovarian and Endometrial Cancers, A ComboMATCH Treatment TrialNCT05554328
Recurrent Endom...
Recurrent Fallo...
Recurrent Ovari...
Recurrent Prima...
Biopsy
Biospecimen Col...
Bone Marrow Asp...
Computed Tomogr...
Echocardiograph...
Multigated Acqu...
Olaparib
Selumetinib Sul...
18 Years - National Cancer Institute (NCI)
Selumetinib Sulfate in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)NCT03213691
Advanced Malign...
Ann Arbor Stage...
Ann Arbor Stage...
Recurrent Child...
Recurrent Child...
Recurrent Malig...
Recurrent Neuro...
Refractory Mali...
Refractory Neur...
Refractory Non-...
Refractory Prim...
Laboratory Biom...
Selumetinib
Selumetinib Sul...
12 Months - 21 YearsNational Cancer Institute (NCI)
Selumetinib in Treating Patients With Neurofibromatosis Type 1 and Cutaneous NeurofibromaNCT02839720
Cutaneous Neuro...
Neurofibromatos...
Optic Nerve Gli...
Laboratory Biom...
Selumetinib Sul...
18 Years - National Cancer Institute (NCI)
Selumetinib Sulfate in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer With KRAS G12R MutationsNCT03040986
KRAS NP_004976....
Stage III Pancr...
Stage IV Pancre...
Laboratory Biom...
Selumetinib Sul...
18 Years - National Cancer Institute (NCI)
Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)NCT03155620
Advanced Malign...
Ann Arbor Stage...
Ann Arbor Stage...
Histiocytic Sar...
Juvenile Xantho...
Langerhans Cell...
Malignant Gliom...
Recurrent Child...
Recurrent Epend...
Recurrent Ewing...
Recurrent Gliom...
Recurrent Hepat...
Recurrent Lange...
Recurrent Malig...
Recurrent Malig...
Recurrent Medul...
Recurrent Neuro...
Recurrent Non-H...
Recurrent Osteo...
Recurrent Perip...
Recurrent Prima...
Recurrent Rhabd...
Recurrent Soft ...
Refractory Ewin...
Refractory Glio...
Refractory Hepa...
Refractory Lang...
Refractory Mali...
Refractory Mali...
Refractory Medu...
Refractory Neur...
Refractory Non-...
Refractory Oste...
Refractory Peri...
Refractory Prim...
Refractory Rhab...
Refractory Rhab...
Rhabdoid Tumor
Stage III Osteo...
Stage III Soft ...
Stage IV Osteos...
Stage IV Soft T...
Stage IVA Osteo...
Stage IVB Osteo...
Wilms Tumor
Biopsy
Biospecimen Col...
Bone Marrow Asp...
Bone Scan
Computed Tomogr...
Ensartinib
Erdafitinib
Laboratory Biom...
Larotrectinib S...
Magnetic Resona...
Mutation Carrie...
Olaparib
Palbociclib
Pharmacological...
Positron Emissi...
Radionuclide Im...
Samotolisib
Selpercatinib
Selumetinib Sul...
Tazemetostat
Tipifarnib
Ulixertinib
Vemurafenib
X-Ray Imaging
12 Months - 21 YearsNational Cancer Institute (NCI)
A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade GliomaNCT03871257
Low Grade Gliom...
Neurofibromatos...
Visual Pathway ...
Carboplatin
Magnetic Resona...
Quality-of-Life...
Questionnaire A...
Selumetinib Sul...
Vincristine Sul...
2 Years - 21 YearsNational Cancer Institute (NCI)
Cediranib Maleate and Selumetinib Sulfate in Treating Patients With Solid MalignanciesNCT01364051
Metastatic Mela...
Refractory Mali...
Stage IV Cutane...
Unresectable Ma...
Cediranib
Cediranib Malea...
Laboratory Biom...
Pharmacological...
Selumetinib
Selumetinib Sul...
18 Years - National Cancer Institute (NCI)
Selumetinib Sulfate in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer With KRAS G12R MutationsNCT03040986
KRAS NP_004976....
Stage III Pancr...
Stage IV Pancre...
Laboratory Biom...
Selumetinib Sul...
18 Years - National Cancer Institute (NCI)
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: